People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pharmajet, Inc. | — | Biotech / Pharma | Series B | $66.9M | $568.1M | 2012 |
Marcus Pedriks at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marcus Pedriks on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Jordan | 1 | 12 |
| Jeffrey Jordan | 1 | 6 |
| Rajen Dalal | 1 | 5 |
| Kim Duncan | 1 | 2 |
| Cody Smith | 1 | 2 |
| Linda Sonntag | 1 | 2 |
| Rodney Smith | 1 | 2 |
| John Buckley | 1 | 2 |
| James Bowman | 1 | 1 |
| Ronald Lowy | 1 | 1 |
| Jeffrey A. Jordan | 1 | 1 |
| John (Spike) Buckley | 1 | 1 |
| Paul Marcaccio | 1 | 1 |
| Mischa Kowall | 1 | 1 |
| Marie Mazur | 1 | 1 |
| Marian Wentworth | 1 | 1 |
| Chris Cappello | 1 | 1 |
| Kevin Lorenz | 1 | 1 |
| Markus Pedricks | 1 | 1 |
| Gary Calmenson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.